Control nucleic acids, and compositions, kits, and uses thereof

    公开(公告)号:US11542540B2

    公开(公告)日:2023-01-03

    申请号:US16622113

    申请日:2018-06-12

    摘要: Provided are methods, as well as compositions, kits, and systems for preparing optimized control nucleic acids (polynucleotides) having reduce nucleic acid damage. Provided nucleic acid compositions provide reduced artifacts as compared to nucleic acid compositions prepared by conventional methods. Provided compositions are useful control in a variety of applications, including, but not limited to sequencing workflows to effectively monitor sensitivity, accuracy and/or precision of data.

    OPTICAL SYSTEMS AND METHODS FOR BIOLOGICAL ANALYSIS

    公开(公告)号:US20220412890A1

    公开(公告)日:2022-12-29

    申请号:US17825222

    申请日:2022-05-26

    IPC分类号: G01N21/64

    摘要: An instrument for processing and/or measuring a biological process comprises a plurality of filter assemblies configured to be interchangeably located along at least one of the optical paths. The plurality of filter components includes a first filter assembly characterized by a first optical power and a first filter having a first filter function, the first filter function characterized by at least one of a first low-pass wavelength or a first high-pass wavelength. The second filter assembly is characterized by a second optical power and a second filter having a second filter function, the second filter function comprising at least one of a second low-pass wavelength that is different than the first low-pass wavelength or a second high-pass wavelength that is different than the first high-pass wavelength.

    Cell Culture Media Tablets and Methods of Manufacture

    公开(公告)号:US20220372435A1

    公开(公告)日:2022-11-24

    申请号:US17761879

    申请日:2020-09-17

    发明人: Mwita PHELPS

    IPC分类号: C12N5/00

    摘要: Described herein are efficiently dissolving tablets of dry cell culture media, feeds, supplements, media subgroups, buffer concentrates, or media components useful in culturing cells or microorganisms, methods of manufacturing, and methods of use. In particular, formulations of tableted cell culture media feeds, supplements, media subgroups, or buffer concentrates are described.

    Sample Stream Centration
    76.
    发明申请

    公开(公告)号:US20220349807A1

    公开(公告)日:2022-11-03

    申请号:US17729440

    申请日:2022-04-26

    IPC分类号: G01N15/14

    摘要: Provided are, inter alia, flow centration components that can be used in flow cytometers and other applications. A flow centrator can define central axis, a proximal end, and a distal end, and having a central bore extending within the flow centration component in the direction of the central axis; the flow centration component defining a splined outer surface that defines a plurality of circumferentially arranged bypass flute channels, the plurality of bypass flute channels extending in the direction of the central axis, and each of the bypass flute channels having a depth and a length. Also provided are related methods that utilize the disclosed components.

    SERUM-FREE SUSPENSION SYSTEM FOR LENTIVIRAL PRODUCTION

    公开(公告)号:US20220348964A1

    公开(公告)日:2022-11-03

    申请号:US17860833

    申请日:2022-07-08

    IPC分类号: C12N15/86 C12N7/00

    摘要: A lentiviral vector production system comprises (a) a lentiviral culture supplement to control cell growth, (b) a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, (c) a lentiviral production enhancer comprising sodium propionate, sodium butyrate, and caffeine to boost lentiviral production, wherein the lentiviral vector production system is serum-free. A method of lentiviral vector production comprises using the lentiviral production system. Another method for lentiviral vector production comprises (a) culturing eukaryotic cells in a serum-free medium, (b) providing a lentiviral culture supplement to control cell growth, (c) transfecting the cells with a lentiviral vector using a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, and (d) providing a lentiviral production using a lentiviral production enhancer comprising sodium propionate, sodium butyrate capable of boosting lentiviral production.